@article{84a6317bf4504201b249d3cb49999a40,
title = "Sodium Bicarbonate Use During Pediatric Cardiopulmonary Resuscitation: A Secondary Analysis of the ICU-RESUScitation Project Trial∗",
abstract = "Objectives: To evaluate associations between sodium bicarbonate use and outcomes during pediatric in-hospital cardiac arrest (p-IHCA). Design: Prespecified secondary analysis of a prospective, multicenter cluster randomized interventional trial. Setting: Eighteen participating ICUs of the ICU-RESUScitation Project (NCT02837497). Patients: Children less than or equal to 18 years old and greater than or equal to 37 weeks post conceptual age who received chest compressions of any duration from October 2016 to March 2021. Interventions: None. Measurements and Main Results: Child and event characteristics, prearrest laboratory values (2-6 hr prior to p-IHCA), pre- and intraarrest hemodynamics, and outcomes were collected. In a propensity score weighted cohort, the relationships between sodium bicarbonate use and outcomes were assessed. The primary outcome was survival to hospital discharge. Secondary outcomes included return of spontaneous circulation (ROSC) and survival to hospital discharge with favorable neurologic outcome. Of 1,100 index cardiopulmonary resuscitation events, median age was 0.63 years (interquartile range, 0.19-3.81 yr); 528 (48.0%) received sodium bicarbonate; 773 (70.3%) achieved ROSC; 642 (58.4%) survived to hospital discharge; and 596 (54.2%) survived to hospital discharge with favorable neurologic outcome. Among the weighted cohort, sodium bicarbonate use was associated with lower survival to hospital discharge rate (adjusted odds ratio [aOR], 0.7; 95% CI, 0.54-0.92; p = 0.01) and lower survival to hospital discharge with favorable neurologic outcome rate (aOR, 0.69; 95% CI, 0.53-0.91; p = 0.007). Sodium bicarbonate use was not associated with ROSC (aOR, 0.91; 95% CI, 0.62-1.34; p = 0.621). Conclusions: In this propensity weighted multicenter cohort study of p-IHCA, sodium bicarbonate use was common and associated with lower rates of survival to hospital discharge.",
keywords = "cardiopulmonary resuscitation, child; infant, neonate, sodium bicarbonate",
author = "{for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network (CPCCRN) and National Heart Lung and Blood Institute ICU-RESUScitation Project Investigators} and Katherine Cashen and Reeder, {Ron W.} and Tageldin Ahmed and Bell, {Michael J.} and Berg, {Robert A.} and Candice Burns and Carcillo, {Joseph A.} and Carpenter, {Todd C.} and Dean, {J. Michael} and Diddle, {J. Wesley} and Myke Federman and Fink, {Ericka L.} and Frazier, {Aisha H.} and Friess, {Stuart H.} and Kathryn Graham and Mark Hall and Hehir, {David A.} and Horvat, {Christopher M.} and Huard, {Leanna L.} and Tensing Maa and Arushi Manga and McQuillen, {Patrick S.} and Morgan, {Ryan W.} and Mourani, {Peter M.} and Nadkarni, {Vinay M.} and Naim, {Maryam Y.} and Daniel Notterman and Palmer, {Chella A.} and Pollack, {Murray M.} and Carleen Schneiter and Sharron, {Matthew P.} and Neeraj Srivastava and David Wessel and Wolfe, {Heather A.} and Yates, {Andrew R.} and Zuppa, {Athena F.} and Sutton, {Robert M.} and Meert, {Kathleen L.}",
note = "Funding Information: Drs. Reeder{\textquoteright}s, Carcillo{\textquoteright}s, Carpenter{\textquoteright}s, Dean{\textquoteright}s, Fink{\textquoteright}s, Frazier{\textquoteright}s, Friess{\textquoteright}, Hall{\textquoteright}s, Manga{\textquoteright}s, Morgan{\textquoteright}s, Mourani{\textquoteright}s, Nadkarni{\textquoteright}s, Naim{\textquoteright}s, Palmer{\textquoteright}s, Pollack{\textquoteright}s, Wessel{\textquoteright}s, Wolfe{\textquoteright}s, Yates{\textquoteright}, Zuppa{\textquoteright}s, Sutton{\textquoteright}s, and Meert{\textquoteright}s institutions received funding from the National Institutes of Health (NIH). Drs. Reeder, Berg, Carcillo, Carpenter, Dean, Fink, Frazier, Friess, Hall, Horvat, Maa, McQuillen, Morgan, Mourani, Nadkarni, Naim, Palmer, Pollack, Wessel, Wolfe, Yates, Zuppa, and Meert received support for article research from the NIH. Dr. Berg{\textquoteright}s institution received funding from the National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network grant and the National Heart, Lung, and Blood Institute (NHLBI) ICU-RESUS trial grant. Dr. Fink{\textquoteright}s institution received funding from the Neurocritical Care Society; she received funding from the American Board of Pediatrics and the Child Neurology Society. Dr. Friess received funding from an expert witness testimony. Dr. Hall received funding from Abbvie, La Jolla Pharmaceuticals, and Kiadis. Drs. Horvat, Maa, and McQuillen{\textquoteright}s institutions received funding from the NICHD. Dr. Horvat{\textquoteright}s institution received funding from the National Institute of Neurological Disorders and Stroke. Dr. Maa{\textquoteright}s institution received funding from the NHLBI. Dr. Mourani disclosed the off-label product use of sodium bicarbonate. Dr. Pollack disclosed work for hire. Dr. Wolfe received funding from The Debriefing Academy and Zoll. The remaining authors have disclosed that they do not have any potential conflicts of interest. Funding Information: Members of the CPCCRN/ICURESUScitation Project Investigators are the authors listed on the first page and the following individuals: Robert Bishop, MD (Department of Pediatrics, University of Colorado School of Medicine and Children{\textquoteright}s Hospital Colorado, Aurora, CO), Matthew Bochkoris, MD (Department of Critical Care Medicine, UPMC Children{\textquoteright}s Hospital of Pittsburgh, University of Pittsburgh, Pittsburgh, PA), Richard Fernandez, MD (Department of Pediatrics, Nationwide Children{\textquoteright}s Hospital, The Ohio State University, Columbus, OH), Deborah Franzon, MD (Department of Pediatrics, Benioff Children{\textquoteright}s Hospital, University of California, San Francisco, San Francisco, CA), William Landis (Department of Anesthesiology and Critical Care Medicine, The Children{\textquoteright}s Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA), Ashley Siems, MD (Department of Pediatrics, Children{\textquoteright}s National Hospital, George Washington University School of Medicine, Washington, DC), Sarah Tabbutt, MD, PhD (Department of Pediatrics, Benioff Children{\textquoteright}s Hospital, University of California, San Francisco, San Francisco, CA), Bradley Tilford, MD (Department of Pediatrics, Children{\textquoteright}s Hospital of Michigan, Central Michigan University, Detroit, MI), Shirley Viteri, MD (Department of Pediatrics, Nemours Cardiac Center, Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE), and Anil Sapru (Department of Pediatrics, Mattel Children{\textquoteright}s Hospital, University of California Los Angeles, Los Angeles, CA). Supported, in part, by the following grants from the National Institutes of Health National Heart, Lung, and Blood Institute and the Eunice Kennedy Shriver National Institute of Child Health and Human Development: R01HL131544, U01HD049934, UG1HD049981, UG1HD049983, UG1HD050096, UG1HD063108, UG1HD083166, UG1HD083170, UG1HD083171, and K23HL148541. Publisher Copyright: {\textcopyright} 2022 Lippincott Williams and Wilkins. All rights reserved.",
year = "2022",
month = oct,
day = "1",
doi = "10.1097/PCC.0000000000003045",
language = "English",
volume = "23",
pages = "784--792",
journal = "Pediatric Critical Care Medicine",
issn = "1529-7535",
number = "10",
}